Image

Asia-Pacific Dermal Fillers Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Sep 2022
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 87
  • No of Figures: 43
  • Medical Devices
  • Published Report
  • Sep 2022
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 87
  • No of Figures: 43

Asia-Pacific Dermal Fillers Market, By Product Type (Biodegradable Dermal Fillers, Non-Biodegradable Dermal Fillers), Material Type (Natural Dermal Fillers, Synthetic Dermal Fillers), Application (Face Lift, Rhinoplasty, Reconstructive Surgery, Facial Line Correction, Lip Enhancement, Sagging Skin, Cheek Depression, Skin Smoothing, Dentistry, Aesthetic Restoration, Lip Plum, Scar Treatment, Chin Augmentation, Lipoatrophy Treatment, Earlobe Rejuvenation and Others), Drug Type (Branded, Generic), End User (Dermatology Clinics, Ambulatory Surgical Centers, Hospitals, Academic Research Institutes And Others), Distribution Channel (Direct Tender, Drug Stores, Retail Pharmacy, Online Pharmacy and Others)- Industry Trends and Forecast to 2029.

Dermal Fillers Market

Asia-Pacific Dermal Fillers Market Analysis and Insight

The dermal filler is gel-like substances that are injected underneath the skin to restore lost volume, often creases and smooth lines or enhance facial contours. Dermal fillers usage has rapidly grown in recent years because of various offerings in the enhancing aesthetic and rejuvenate improvements that were previously only achievable with surgeries. These are becoming very popular for facial rejuvenation methods. Being minimally invasive dermal filler shows instantaneous results in cosmetic volume replacement therapies. These devices provide volume to the face, boost and enhance the quality of the skin. Various methods such as injections are used for augmentation. These fillers can give fuller, plumper lips for aesthetic purposes. There are many types of dermal fillers that can be injected in lips and around mouth that keep the volume of lips either temporally or permanently depending on the type of product used. Some market players are involved in the new and innovative products, and their products are under pipelines. During the last few years, new innovative dermal fillers products have been developed for increasing the market growth of the dermal fillers market, and the market players are enhancing their product portfolio. Many market players are involved in the manufacturing of dermal fillers with innovations that pave the way for market growth.

Dermal Fillers Market

Dermal Fillers Market

Data Bridge Market Research analyses that the dermal fillers market is expected to reach the value of USD 1,901.14 million by 2029, at a CAGR of 12.6% during the forecast period 2022-2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Year

2020 (Customizable to 2019-2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Product Type (Biodegradable Dermal Fillers, Non-Biodegradable Dermal Fillers), Material Type (Natural Dermal Fillers, Synthetic Dermal Fillers), Application (Face Lift, Rhinoplasty, Reconstructive Surgery, Facial Line Correction, Lip Enhancement, Sagging Skin, Cheek Depression, Skin Smoothing, Dentistry, Aesthetic Restoration, Lip Plum, Scar Treatment, Chin Augmentation, Lipoatrophy Treatment, Earlobe Rejuvenation and Others), Drug Type (Branded, Generic), End User (Dermatology Clinics, Ambulatory Surgical Centers, Hospitals, Academic Research Institutes And Others), Distribution Channel (Direct Tender, Drug Stores, Retail Pharmacy, Online Pharmacy and Others)

Countries Covered

Japan, Australia, South Korea, China, India, Thailand, Singapore, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.

Market Players Covered

Allergan(A Subsidiary of Abbvie, Inc.), Prollenium Medical Technologies, Suneva Medical, Revance Therapeutics, Inc., FillMed Laboratories, Anika Therapeutics, Inc, Ipsen Pharma, BIOXIS Pharmaceuticals, Zimmer Aesthetic, Zhejiang Jingjia Medical Technology Co. Ltd., Medytox, Contura International ltd., Shanghai Reyoungel Medical Technology Company Limited, Humedix (A subsidiary of HUONS GLOBAL),Galderma Laboratories, L.P., Merz North America, Inc. (A Subsidiary of Merz Pharma),Croma-Pharma GmbH, Sinclair Pharma (A Subsidiary of Huadong Medicine Co., Ltd.),Teoxane, BioPlus Co., Ltd., Amalian, Givaudan, Mesoestetic, Sosum Global, DSM, IBSA Nordic ApS,among others.

Market Definition

Dermal fillers are substances designed to be injected into the skin to add fullness and volume. The substances used in dermal fillers include Calcium hydroxylapatite (a mineral-like compound found in bones), Hyaluronic acid, Polyalkylimide, Polylactic acid, Polymethyl-methacrylate microspheres (PMMA). Dermal fillers can be classified based on several criteria, including the deep dermis, depth of implantation (a superficial midterms and upper, and subcutaneous levels); longevity of correction (temporary and permanent); allergenicity, the composition of the agent (allografts, semi/fully synthetic, xenografts, or autologous); and stimulatory behaviour (physiologic processes of endogenous tissue proliferation) versus replacement fillers (space-replacing effect).

Temporary dermal fillers such as HA and collagen are biodegradable and last from 4 to 9 months. The prospective side effects and dissatisfaction are also short-lived. Therefore, temporary fillers are always used as the first line of therapy to save long-lasting fillers for future patient visits.

Permanent fillers are essentially used in the alteration of deep lines and furrows of the skin, which are beyond normal facial wrinkles. They are considered an excellent option in facial rejuvenation, especially in HIV lipodystrophy. Polymethyl methacrylate (PMMA) is mostly used for safe, effective, and long-lasting effects.

Dermal Fillers Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Rising prevalence of minimally-invasive procedures

The use of minimally invasive procedures has been shifted as compared to traditional methods for aesthetic and cosmetics surgeries techniques including laser and other energy-based devices. For the use of surgical or non-surgical procedures, specially-designed instruments have been developed for minimally used procedures. These anti-aging devices help in reducing the visual effects of skin aging by revitalizing and tightening the skin, which gives a younger look.

Minimally-invasive surgery is a procedure conducted with the assistance of a scope of viewing and specially-equipped surgical instruments. It targets facial irregularities including wrinkles and fine lines, and decreases volume and contour, and unwanted fat. These have essentially no risk of serious adverse events as the procedures allow no cuts or minimal cuts with lesser recovery time which is increasing the demand for use of minimally invasive procedures. Minimally-invasive energy-based treatments for skin tightening, wrinkle reduction, face contouring, and skin rejuvenation have a high demand in the world. Other reasons driving the demand for these procedures are increasing aging people and rising requirement of healthcare facilities which can further result in decrease in burden on healthcare facilities.

With rising technological advancements and communications, people are more aware of aesthetic devices and procedures that are well performed in the healthcare field, impacting the adoption of minimally invasive procedures positively in the upcoming era. Thus, the increasing prevalence of minimally invasive procedures is expected to drive growth in the dermal fillers market.

  • Increasing geriatric population

The geriatric population is expanding for longer life span and is reported to have increasing skin ageing conditions. The speed of aging population is increasing exponentially in the world whereas European countries have certain cultural, social, and economic characteristics in common with similar aspirations. As people start aging, increase in appearance to appear as younger raises which ultimately develops interest in utilization of aesthetic procedures.

Rising improving healthcare delivery and its scenario in the Middle Eastern countries among the percentage of elderly people have resulted in better patients’ outcome services.

Opportunities

  • Increasing funding activities for aesthetic research

Plastic surgery, unwanted hair removal, skin tightening, anti-aging, excess fat removal, body contouring, and several other cosmetic procedures that are to be performed through minimally invasive procedures follow under medical aesthetic devices that are used for increased appearances, beautification and other improvement part of body. Various foundations and government organizations are investing a large amount in aesthetic research.

  • Advancement in the new dermal fillers

Dermal fillers are in the form of gel-like substances, which are injected beneath the skin to restore the lost volume, soften creases and smooth lines. It is also used to enhance facial contours; each year more than 1 million people prefer this popular facial transformation treatment to restore the wrinkles and appearance of facial lines. Dermal fillers are an effective treatment way to look younger without downtime or surgery. Dermal fillers drug is injected into the skin which helps in filling the facial wrinkles. There are different types of dermal fillers drugs available, the most common types are Calcium hydroxylapatite, Hyaluronic acid, Polyalkylimide, Polylactic acid, and others. Advancement in the dermal fillers brands will help to boost the demand of the market.

Restrains/ Challenges

  • High cost of aesthetic procedures

Cost is always a consideration in the elective procedure. The cost of dermal filler is depending on the type of filler and the amount is used in the treatment. Also, the treatment cost is based on the qualifications and expertise of the person performing the dermal fillers treatment. The cosmetic treatment of dermal filler is a safe outpatient procedure and it is a very popular treatment for restoring lost volume and treating some signs of aging, but the high cost of the procedures is expected to hamper the demand of the market

  • Lack of skilled professionals

Aesthetic treatment procedures are of different type’s laser-based technology, energy-based technology, and intense pulse light among others. All such techniques need qualified interpersonal skills in order to carry out effective treatment.

Moreover, rapid technological advancement in this field also lead to lack of skilled professionals. Lack of skilled professionals pose major challenge while device handling and carrying out surgical procedures.

  • Availability of alternatives

Various open surgical procedures act as an alternative treatment approach for hair removal and skin related surgeries. Aesthetic techniques using intense pulse light, lasers and other energy based devices poses several side effects and also costs too high which led the patients to look for other alternative treatment options such as resection, among others. Moreover, patient favorable conditions also reflect the need of resection procedure. Below provided study results depicts the importance of alternative treatment procedures.

Recent Developments

  • In April 2022, Sinclair Pharma announced the company has received European CE mark for Perfectha Lidocaine in the treatment of wrinkle correction, facial contouring, and volume restoration. This CE certificate results in launch of Perfectha Lidocaine in the UK and all major European markets.

Dermal Fillers Market Segmentation

The dermal fillers market is segmented on the basis of product type, material type, application, drug type, end user, and distribution channel. The growth among segments helps you analyses niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

By Product Type

  • Biodegradable Dermal Fillers
  •  Non-Biodegradable Dermal Fillers

On the basis of product type, the dermal fillers market is segmented into biodegradable dermal fillers and non-biodegradable dermal fillers.

By Material Type

  • Natural Dermal Fillers
  • Synthetic Dermal Fillers

On the basis of material type, the market is segmented into natural dermal fillers and synthetic dermal fillers.

By Application

  • Face Lift
  • Rhinoplasty
  • Reconstructive Surgery
  • Facial Line Correction
  • Lip Enhancement
  • Sagging Skin
  • Cheek Depression
  • Skin Smoothing
  • Dentistry
  • Aesthetic Restoration
  • Lip Plum
  • Scar Treatment
  • Chin Augmentation
  • Lipoatrophy Treatment
  • Earlobe Rejuvenation
  • Others

On the basis of application, the market is segmented into face lift, rhinoplasty, reconstructive surgery, facial line correction, lip enhancement, sagging skin, cheek depression, skin smoothing, dentistry, aesthetic restoration, scar treatment, chin augmentation, lipoatrophy treatment, earlobe rejuvenation and others.

By Drug Type

  • Branded
  • Generic

On the basis of drug type, the market is segmented into branded and generic.

By End User

  • Dermatology Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Academic Research Institutes
  • Others

On the basis of end user, the market is segmented into dermatology clinics, ambulatory surgical centers, hospitals, academic research institutes and others.

By Distribution Channel

  • Direct Tender
  • Drug Stores
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Dermal Fillers Market

On the basis of distribution channel, the market is segmented into direct tender, drug stores, retail pharmacy, online pharmacy and others.

Dermal Fillers Market Regional Analysis/Insights

The dermal fillers market is analyzed and market size insights and trends are provided by country, product type, material type, application, drug type, end user, and distribution channel as referenced above.

The countries covered in the dermal fillers market report are Japan, Australia, South Korea, China, India, Thailand, Singapore, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.

Japan is expected to dominate the market due to healthcare infrastructure and strategic collaborations among key market players in the region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Dermal Fillers Market Share Analysis

The dermal fillers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus on the dermal fillers market.

Some of the major players operating in the market are Allergan(A Subsidiary of Abbvie, Inc.), Prollenium Medical Technologies, Suneva Medical, Revance Therapeutics, Inc., FillMed Laboratories, Anika Therapeutics, Inc, Ipsen Pharma, BIOXIS Pharmaceuticals, Zimmer Aesthetic, Zhejiang Jingjia Medical Technology Co. Ltd., Medytox, Contura International ltd., Shanghai Reyoungel Medical Technology Company Limited, Humedix (A subsidiary of HUONS GLOBAL),Galderma Laboratories, L.P., Merz North America, Inc. (A Subsidiary of Merz Pharma),Croma-Pharma GmbH, Sinclair Pharma (A Subsidiary of Huadong Medicine Co., Ltd.),Teoxane, BioPlus Co., Ltd., Amalian, Givaudan, Mesoestetic, Sosum Global, DSM, IBSA Nordic ApS,among others.


SKU-
Why Choose Us


Frequently Asked Questions

The Asia-Pacific Dermal Fillers Market value is expected USD 1,901.14 million by 2029.
The Asia-Pacific Dermal Fillers Market is to grow at a CAGR of 12.6% during the forecast by 2029.
The major players operating in the Asia-Pacific Dermal Fillers Market are Allergan(A Subsidiary of Abbvie, Inc.), Prollenium Medical Technologies, Suneva Medical, Revance Therapeutics, Inc., FillMed Laboratories, Anika Therapeutics, Inc, Ipsen Pharma, BIOXIS Pharmaceuticals, Zimmer Aesthetic, Zhejiang Jingjia Medical Technology Co. Ltd., Medytox, Contura International ltd., Shanghai Reyoungel Medical Technology Company Limited, Humedix (A subsidiary of HUONS GLOBAL),Galderma Laboratories, L.P., Merz North America, Inc. (A Subsidiary of Merz Pharma),Croma-Pharma GmbH, Sinclair Pharma (A Subsidiary of Huadong Medicine Co., Ltd.),Teoxane, BioPlus Co., Ltd., Amalian, Givaudan, Mesoestetic, Sosum Global, DSM, IBSA Nordic ApS,among others.
The major countries covered in the Asia-Pacific Dermal Fillers Market are Japan, Australia, South Korea, China, India, Thailand, Singapore, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.